Hunan Shangzhonghe Biopharmaceutical

Hunan Shangzhonghe Biopharmaceutical is a Chinese pharmaceutical company based in Changsha, Hunan, specializing in the development, production, and commercialization of high-quality chemical drugs and innovative therapies. The company holds a Marketing Authorization Holder (MAH) certificate and has successfully advanced several products through the regulatory pipeline, including the first Aspirin Vitamin C Effervescent Tablets to pass consistency evaluation in China. Its pipeline includes treatments for cardiovascular diseases, muscle spasms, and allergic conditions, as well as early-stage research in oncology. Shangzhonghe is committed to providing affordable and effective healthcare solutions through its integrated R&D and manufacturing capabilities.